chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reports SOB and throbbing pain in shoulder immediately after receiving the vaccine on 9/11/19.  Later that night she had chest tightness.  Thursday night 9/12/19 pain radiated to her neck.  Friday 9/13/19 patient took an aspirin because her neck was still hurting.  Patient said she has had SOB and throbbing pain after receiving the vaccine in the past but symptoms stopped by the next day.
Red, warm rash at injection site, low grade fever 1 week after first shot. Same reaction within 24 hrs with second dose of moderna vaccine.
pain in the arm; Fatigue; Head ache; body ache; low grade fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm), FATIGUE (Fatigue), HEADACHE (Head ache), MYALGIA (body ache) and PYREXIA (low grade fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in the arm), FATIGUE (Fatigue), HEADACHE (Head ache), MYALGIA (body ache), PYREXIA (low grade fever) and CHILLS (chills). At the time of the report, PAIN IN EXTREMITY (pain in the arm), FATIGUE (Fatigue), HEADACHE (Head ache), MYALGIA (body ache), PYREXIA (low grade fever) and CHILLS (chills) outcome was unknown.            Concurrent medical conditions included Thyroid Medication. Treatment information was not provided.   This case was linked to MOD-2021-404688 (Patient Link).
Severe parosmia, dysgeusia - lasting for more than two months; still suffering from both.
Patient states that on the evening she received her flu vaccine she began to experience weakness in her arm that spread to more generalized weakness. Also had chest pain and fatigue. Says she was not able to leave bed for the 10 days following vaccine - never saw MD for x-ray/testing because she felt too ill to do so.
Next day pain to right tempel.  3 short violent stabs of pain.  Couldnt move, scared I  get to the phone to call for help.  Then it was gone.
Narrative:  This patient received two doses of Moderna COVID 19 Vaccine in  Feb/Mar 2021. The patient tested positive for COVID 19 on JAN 2022. The patient was admitted to the hospital for confusion, amnesia, hypoxia, and pneumonia. The patient was treated with dexamethasone. The patient was discharged on 26 Jan 2022 to the community nursing home. The patient died on 8 Mar 2022.
11/03/22 presents to ED for "shortness of breath". PMHx of "DVT"
70kg 51 yo F was given Shingrex vaccine in her left deltoid on 4/22/22 at 1519 (Lot #7BC47).   On 4/25/22, patient called to c/o swelling the size of a large peach and tenderness to L axillary since 4/24/22 and redness 0.5 x 1.5 in at L deltoid injection site since 4/23/22.  Pt had tried light massage without relief.  On physical assessment, MD found lymph nodes over left neck and left axilla areas.  Patient reports appearance of lymphadenopathies over the left side of her neck. Some rash at the injection site.  Diagnosed with acute lymphadenitis and prescribed ibuprofen 400mg po daily for 7 days. Treat with warm compresses.
Patient presented for evaluation on 5/18/2010. Generalized purpuric rash on the trunk and extremities. No mucocutaneous involvement. Low grade fever was present - 99.8 F. No thrombocytopenia. Microscopic hematuria, pyuria and proteinuria present on UA. Urine culture grew E. coli.
This spontaneous report was received from a medical assistant referring to unspecified number of patients of unknown ages and genders. The patient's medical history or concurrent conditions were not reported. On unknown dates since 01-NOV-2016 (reported as "excursion started on 01-NOV-2016 and vaccinations may have occurred since then"), the patients were vaccinated with unspecified doses in series of improperly stored doses of GARDASIL 9 (which had the lot # L024993, expiration date 17-OCT-2017) (dose, route and vaccination site were not informed). Information regarding concomitant medication was not provided. No adverse effects were reported. It was also reported that the temperature was 12.6 C. The time frame was 168 hours. There was not previous temperature excursion. The call was not because of a "data logger". And there was not product quality complaint involved. A list of patients and actual dates of administration was not available. Additional information has been requested.
patient reports weakness in left arm and shoulder which he noticed upon waking the next morning. reports soreness that has not resolved, strengthed estimated to be at apporoximately 75-80% in his only functioning arm.
period cramps; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 01Feb2021 (Batch/Lot number: unknown) at the age of 32 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Endometriosis", start date: Dec2020 (unspecified if ongoing), notes: removal of ovarian Cyst and Endometriosis; "Allergic to Shrimp" (unspecified if ongoing), notes: May be allergic to shrimp; still getting tested.; "Unknown Ptential Virus Not COVID", start date: 10Mar2021, stop date: 10Mar2021, notes: significant Vomiting , Diarrhea hospitalized But not admitted; "Endometriosis and Fibroids", start date: Nov2016 (unspecified if ongoing), notes: Removal of uterine fibroid and Endometriosis. Concomitant medication(s) included: KYLEENA taken for uterine leiomyoma, start date: Aug2018 (ongoing); TYLENOL. Vaccination history included: Bnt162b2 (Dose Number: 1, site: Right upper arm, Route: Intramuscular), administration date: 11Jan2021, when the patient was 32 years old, for COVID-19 Immunization. The following information was reported: DYSMENORRHOEA (non-serious) with onset 01Feb2021, outcome "not recovered", described as "period cramps". Therapeutic measures were not taken as a result of dysmenorrhoea.  Additional information: Patient have endometriosis. Patient not sure if that was related to this, but wanted to report an event so your team may study this side effect (or just explain to me why it happens because I'm curious). Obviously patient still got third injection so it didn't deter me, but patient have gotten severe period cramps within an hour after the second and third dose. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101480028 similar report from same reporter
A non-serious spontaneous report of administration of expired FLUMIST was received from a nurse concerning a 21-year-old female. Neither medical history nor concomitant medications were reported. On 12-Jan-2009, the patient received expired FLUMIST vaccine. The vaccine had an expiration date of 11-Jan-2009. There was no adverse events associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause of the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Additional information was received on 18-Mar-2009 that indicated no adverse events were reported through the medical clinic and patient demographics information received. Additional information was received on 12-May-2009: product complaint investigation results.
Admitted to hospital 7/28 for COVID-19 pneumonia, has worsening hypoxia, requiring 100% FiO2 by HFNC. Admitted to ICU 7/30.
Cellulitis-arm turned red in about 15-20 minutes after immunization and the redness ran down the arm; Cellulitis-arm turned red in about 15-20 minutes after immunization and the redness ran down the arm; This is a spontaneous report from a contactable nurse via Pfizer sales representative. A 69-year-old male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) via an unspecified route of administration on an unspecified date at single dose for immunisation. The patient medical history included cholesterol high and atrial fibrillation (a fib). Concomitant medications were not reported. The patient experienced cellulitis-arm turned red in about 15-20 minutes after immunization and the redness ran down the arm on an unspecified date. The outcome of events was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained.; Sender's Comments: Based on the information currently available, the vaccination with PREVNAR might play a contributory role in triggering the occurrence of cellulitis in arm.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
23Oct90 pt was hosp /w pancytopenia,was treated /w ATGAM for 8 days,remained hospitalized-neutropenic complications,recovered. 26Nov90 rehospitalized-neutropenic complications,recovered,D/C. FEB91 labs showed bone marrow depression
Swollen Lymph notes in left arm pit.  Woke up during the night from the pain.
he'd been in bed with vertigo from the second dose of Pfizer Covid Vaccine for 5 days but was feeling better. His friend said his daughter had the same problem; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VERTIGO (non-serious), outcome "unknown", described as "he'd been in bed with vertigo from the second dose of Pfizer Covid Vaccine for 5 days but was feeling better. His friend said his daughter had the same problem".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The patient received a dose of the vaccine following temperature excursions on unknown dates; No adverse event; This spontaneous report as received from a medical assistant refers to a current 4-month-old patient of unknown gender.  The patient's concurrent conditions, medical history and concomitant medications were not provided.   On an unknown date, the rotavirus vaccine, live, oral, pentavalent (ROTATEQ)  (lot # S013439 with expiration date 03-MAR-2021, lot # S013436 with expiration date 30-JAN-2021, and lot # S006050 with expiration date 12-DEC-2020) underwent a temperature excursion.   Temperature Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) Time frame 7 hours 30 minutes Previous temperature excursion? yes, Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) for 8 hours 30 minutes Was call because of a "data logger"? yes  On an unknown date, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) at a dose of 2 ml (route not provided) as prophylaxis. No adverse events were reported.  This is one of several reports received from the same reporter  This spontaneous report as received from a other health professional refers to a patient of unknown age.    On an unknown date the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # S006050, 2 milliliter for prophylaxis.       On an unknown date the patient experienced product storage error and no adverse event.    The outcome of product storage error and no adverse event is unknown.   The reporter considered product storage error and no adverse event to be not assessed to Rotavirus Vaccine, Live, Oral, Pentavalent(ROTATEQ).     {Additional information has been requested. / Additional information is not expected.}; Sender's Comments:  US-009507513-2005USA003382: US-009507513-2005USA004545: US-009507513-2005USA004950: US-009507513-2005USA004951: US-009507513-2005USA004952: US-009507513-2005USA004954: US-009507513-2005USA004955: US-009507513-2005USA004956: US-009507513-2005USA004957: US-009507513-2005USA004958: US-009507513-2005USA004959: US-009507513-2005USA004960: US-009507513-2005USA004961: US-009507513-2005USA004962: US-009507513-2005USA004963: US-009507513-2005USA004964: US-009507513-2005USA004965: US-009507513-2005USA004966: US-009507513-2005USA004967: US-009507513-2005USA004968: US-009507513-2005USA004969: US-009507513-2005USA004970: US-009507513-2005USA004971: US-009507513-2005USA004972: US-009507513-2005USA004973: US-009507513-2005USA004974: US-009507513-2005USA004975: US-009507513-2005USA004976: US-009507513-2005USA004977: US-009507513-2005USA004978: US-009507513-2005USA004979: US-009507513-2005USA004980: US-009507513-2005USA004981: US-009507513-2005USA004982: US-009507513-2005USA004983: US-009507513-2005USA004984: US-009507513-2005USA004985: US-009507513-2005USA004986: US-009507513-2005USA004987: US-009507513-2005USA004988: US-009507513-2005USA004989: US-009507513-2005USA004990: US-009507513-2005USA004991: US-009507513-2005USA004992: US-009507513-2005USA004993:
Constant pain in both hip area radiating down bilateral thighs worse at nights.; bilateral thighs worse at nights.; Pain in lower back; Constant cough; General body weakness with sleepless nights.; sleepless nights; This is a spontaneous report from a contactable female nurse (patient) via medical information team. An elderly female patient (non pregnant) unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration in arm left on 06Feb2021 14:00 (Lot Number: EL9269) as a single dose at the age of 71 year old for covid-19 immunisation from hospital.  Medical history included high blood pressure. Concomitant medications included levothyroxine, hydrochlorothiazide and diltiazem all taken for an unspecified indication, start and stop date were not reported. The patient previously took betamethasone benzoate, diltiazem. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration in arm left on 16Jan2021 14:00 (Lot Number: EL3249) as a single dose for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with covid prior to vaccination and patient was not tested for COVID-19 post vaccination. On 02Mar2021 03:00,  patient experienced Constant pain in both hip area radiating down bilateral thighs worse at nights. Pain in lower back. Constant cough. General body weakness with sleepless nights which result doctor or other healthcare professional office/clinic visit. Patient was treated with pain medication, x-ray of hip, bone density, refera in repose to the event. The patient underwent lab tests and procedures which included X-ray of hips, bone density measurement (report not provided). The outcome of the events was not recovered.
Chest Pain  786.5  (5-000008)  5/19/09 medical records received DOS 1/27/09 to 2/5/09. FINAL DIAGNOSIS: Atypical chest pain, Hypertension (Systemic), Obesity Post vaccination: chest pain over left breast. ICD-9: 786.5 Chest Pain
On Friday morning, she had pain and bleeding in right nostrils. Had two huge canker sores in mouth. Left side of lip was swollen, crunchy and bloody. Still having pain in nostril.
Patient reported fever.  Also this shot was given to a patient outside of the approved use.  Patient was only 16 years old, this vaccine was approved use for 18+.
Headache, Arthralgia, Fever, CoughWheeze & NauseaVomiting Narrative:
may 26 i developed a severe case of virtago very dizzy ive had this over 3 months now  ive had my ears fully examed even with a vng test    and they found no virtigo and they told me its in my brain.
I experienced some mild symtoms the night after my first injection. I woke up in sweat and a fast beating heart, around 110-120 bpm. I felt like I inhaled a bunch of cotten balls in my lungs. These feelings lasted a few hours then went away.
backache; This is a spontaneous report from a Pfizer-sponsored program, received from a contactable consumer (Patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration on an unspecified date at 1st dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was taking Tylenol and Hydrocodone for his backache. The patient was scheduled to receive his second dose of Pfizer-Biontech Covid19 vaccine tomorrow. He takes hydrocodone for chronic back pain. Will this affect the efficacy of the vaccine? The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Unable to lift arm above head for about 2 weeks; throbbing pain for 2-3 days.
Redness in their eyes; Having a lot of discharge from eyes; Eyes are hurting a lot; Couldn't sleep; Arm was swollen; Fever; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR HYPERAEMIA (Redness in their eyes), EYE DISCHARGE (Having a lot of discharge from eyes), EYE PAIN (Eyes are hurting a lot), INSOMNIA (Couldn't sleep) and PERIPHERAL SWELLING (Arm was swollen) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Cholesterolosis NOS (Cholesterol). Concomitant products included LISINOPRIL for Hypertension and Cholesterolosis NOS.    On 25-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jun-2021, the patient experienced OCULAR HYPERAEMIA (Redness in their eyes), EYE DISCHARGE (Having a lot of discharge from eyes), EYE PAIN (Eyes are hurting a lot), INSOMNIA (Couldn't sleep), PERIPHERAL SWELLING (Arm was swollen) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Swollen arm, at a dose of 325 mg. At the time of the report, OCULAR HYPERAEMIA (Redness in their eyes), EYE DISCHARGE (Having a lot of discharge from eyes), EYE PAIN (Eyes are hurting a lot), INSOMNIA (Couldn't sleep), PERIPHERAL SWELLING (Arm was swollen) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included eye wash.
This 54 year old patient reported receipt of annual FLUVIRIN (lot # 145605) on 10/17/2014 to left deltoid with no other vaccines given. Approximately 8-12 hours later (that afternoon) he noted the site was itching and red. That evening he noted red pimple like macules to his left arm, hand that progressed to his back, sides, chest, right arm/hand, legs and feet. There were no papules, vesicles or involvement of the soles of feet or palms of hands. He denied any fever, nausea, vomiting, headaches, myalgia, arthralgia, or any systemic symptoms. He denied any recent illness or exposure took no new detergents, deodorants, soaps, linen, foods, clothing, etc. He does have multiple seasonal allergies (dust, pollen, grass, mold, cats, and dogs per allergy test as child) and recently moved. He self-treated this reaction with natural element called candela gel with some relief seeking medical care on 10/21/2014. Providers diagnosed with allergic urticaria and place him on topical steroid (hydrocortisone 1% cream) with oral BENADRYL with relief of symptoms. He saw his PCP on 10/27/2014 and was referred to facility on 10/27/2014.
Breakthrough case admission after 4 vaccines Pfizer 3/19/21  Lot# ER2613;  Pfizer 4/9/21 Lot# Ew0158;  Pfizer 1/15/22 Lot# FL3209;  Pfizer 10/14/22 Lot# GH9693
Myalgias; Arthralgias; Pain at injection site; Headache; This is a spontaneous report from a contactable healthcare professional (patient). A 33-year-old female patient received BNT162B2 (lot number: EL0140), via an unspecified route of administration in left arm on 29Dec2020 08:00 at single dose for COVID-19 immunization. Medical history included celiacs disease, dermatitis herpetiformis, melanoma in situ, known allergies: Gluten, and COVID prior vaccination. Concomitant medication included ascorbic acid, betacarotene, calcium sulfate, colecalciferol, cyanocobalamin, ferrous fumarate, folic acid, nicotinamide, pyridoxine hydrochloride, retinol acetate, riboflavin, thiamine mononitrate, tocopheryl acetate, zinc oxide (PRENATAL VITAMINS). Patient experienced myalgias, arthralgias, headache, and pain at injection site on 30Dec2020 00:00. No treatment was received for these events. Outcome of the events was not resolved.
Breakthrough case admission after 3 vaccines Pfizer 3/3/21 lot# EN6198;  Pfizer 3/24/21 lot# EN6208;  Pfizer 1/7/22 lot# FD7218
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Patient's concomitant medication, pertinent medical history and drug allergies were not reported. On 20-MAY-2015, the patient was vaccinated subcutaneously with a dose of VARIVAX (Merck) (lot # K011804 and expiration date 21-AUG-2016). The reporter stated that the administered dose of VARIVAX (Merck) was improperly stored. There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Case number PHEH2013US009414, is an initial spontaneous report received from a physician on 23 Apr 2013: This case refers to an 11-years-old male patient. He received only MENVEO vaccine (batch number: X12013), intramuscularly without being reconstituted with Men A component on 18 Apr 2013. No adverse reaction was reported following this administration error.
been sicker than heck; Initial information was received on 01-Nov-2020 regarding an unsolicited valid non-serious social media case from a consumer.  This case involves patient (unknown demography) who has been sicker than heck (illness), while the patient received vaccine INFLUENZA VACCINE.  The patient's past vaccination(s) included Influenza vaccine. Medical history, medical treatment(s), concomitant medications, and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious was been sicker than hell (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported that the patient got a flu shot twice both times been sicker than hell will never get another.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.